Free Fatty Acids Do Not Acutely Increase Asymmetrical Dimethylarginine Concentrations

Abstract

Concentrations of asymmetrical dimethylarginine (ADMA) and free fatty acids (FFAs) are elevated in insulin resistance which is associated with impaired vascular function. We hypothesized that FFAs could alter vascular tone by affecting ADMA concentrations. Plasma FFA levels were increased in seventeen healthy male volunteers by Intralipid/heparin infusion; hemodynamic and biochemical parameters were measured after 90 minutes. Plasma collected before and during Intralipid/heparin or equivalent synthetic FFAs was incubated with human umbilical vein endothelial cells (HUVECs) in vitro. Intralipid/heparin infusion resulted in an approximately seven-fold increase in plasma FFA levels to 1861 ± 139μmol/l, which was paralleled by increased systemic blood pressure and forearm blood flow. Intralipid/heparin did not affect ADMA (baseline mean 0.59 [95 % confidence interval [CI]: 0.54; 0.64] and 0.56 [CI: 0.51; 0.59] after 90 minutes), but slightly decreased SDMA (from 0.76, [CI: 0.70; 0.83] to 0.71 [CI: 0.64; 0.74], p < 0.05), and had no effect on ADMA/SDMA ratio. There was no correlation between ADMA and FFA concentrations or forearm blood flow. Incubation of HUVECs with FFA-rich plasma or synthetic FFAs induced an ADMA release after 24 hours, but not after 90 minutes. Acutely increased FFA levels caused hemodynamic effects but did not affect ADMA. Prolonged elevation of FFA levels might influence vascular function by increasing ADMA levels.

Key words

Free fatty acids · dimethylarginines · vascular function · endogenous nitric oxide synthase inhibitors · reversed-phase high-performance liquid chromatography

References

• 1 Bergman R N, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus.  Trends Endocrinol Metab. 2000;  11 351-356
• 2 Boden G, Shulman G I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.  Eur J Clin Invest. 2002;  32 Suppl 3 14-23
• 3 Roden M, Stingl H, Chandramouli V, Schumann W C, Hofer A, Landau B R, Nowotny P, Waldhäusl W, Shulman G I. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.  Diabetes. 2000;  49 701-707
• 4 Steinberg H O, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron A D. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.  J Clin Invest. 1997;  100 1230-1239
• 5 Polak K, Schmetterer L, Luksch A, Gruber S, Polska E, Peternell V, Bayerle-Eder M, Wolzt M, Krebs M, Roden M. Free fatty acids/triglycerides increase ocular and subcutaneous blood flow.  Am J Physiol Regul Integr Comp Physiol. 2001;  280 R56-R61
• 6 Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M. FFA-induced endothelial dysfunction can be corrected by vitamin C.  J Clin Endocrinol Metab. 2002;  87 2913-2917
• 7 Beckman J A, Creager M A, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.  Jama. 2002;  287 2570-2581
• 8 Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.  Cardiovasc Res. 1999;  43 542-548
• 9 Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.  Arterioscler Thromb Vasc Biol. 2003;  23 1455-1459
• 10 Tsao P S, Cooke J P. Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction.  J Cardiovasc Pharmacol. 1998;  32 Suppl 3 S48-S53
• 11 Lundman P, Eriksson M J, Stühlinger M, Cooke J P, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine.  J Am Coll Cardiol. 2001;  38 111-116
• 12 Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger R H, Bode-Boeger S M, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel J S, Froelich J C. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension.  J Cardiovasc Pharmacol. 1999;  33 652-658
• 13 Abbasi F, Asagmi T, Cooke J P, Lamendola C, McLaughlin T, Reaven G M, Stuehlinger M, Tsao P S. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.  The American Journal of Cardiology. 2001;  88 1201-1203
• 14 Stühlinger M C, Abbasi F, Chu J W, Lamendola C, McLaughlin T L, Cooke J P, Reaven G M, Tsao P S. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.  Jama. 2002;  287 1420-1426
• 15 Mittermayer F, Mayer B X, Meyer A, Winzer C, Pacini G, Wagner O F, Wolzt M, Kautzky-Willer A. Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes.  Diabetologia. 2002;  45 1372-1378
• 16 Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhäusl W, Roden M. Prevention of in vitro lipolysis by tetrahydrolipstatin.  Clin Chem. 2000;  46 950-954
• 17 Hokanson D E, Sumner D S, Strandness D E Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow.  IEEE Trans Biomed Eng. 1975;  22 25-29
• 18 Pleiner J, Heere-Ress E, Langenberger H, Sieder A E, Bayerle-Eder M, Mittermayer F, Fuchsjäger-Mayrl G, Böhm J, Jansen B, Wolzt M. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans.  Arterioscler Thromb Vasc Biol. 2002;  22 95-100
• 19 Stingl H, Raffesberg W, Nowotny P, Waldhäusl W, Roden M. Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.  Obes Res. 2002;  10 1111-1119
• 20 Artwohl M, Hölzenbein T, Wagner L, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer S M. Levamisole induced apoptosis in cultured vascular endothelial cells.  Br J Pharmacol. 2000;  131 1577-1583
• 21 Ito A, Tsao P S, Adimoolam S, Kimoto M, Ogawa T, Cooke J P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.  Circulation. 1999;  99 3092-3095
• 22 Fard A, Tuck C H, Donis J A, Sciacca R, Di Tullio M R, Wu H D, Bryant T A, Chen N T, Torres-Tamayo M, Ramasamy R, Berglund L, Ginsberg H N, Homma S, Cannon P J. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes.  Arterioscler Thromb Vasc Biol. 2000;  20 2039-2044
• 23 Mittermayer F, Namiranian K, Pleiner J, Schaller G, Wolzt M. Acute E. coli endotoxemia decreases the plasma L-arginine/asymmetrical dimethylarginine ratio in humans.  Clin Sci (Lond). 2004;  106 577-581
• 24 Böger R H, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger S M. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases.  Circ Res. 2000;  87 99-105
• 25 Eid H M, Eritsland J, Larsen J, Arnesen H, Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.  Atherosclerosis. 2003;  166 279-284
• 26 Pereira E C, Bertolami M C, Faludi A A, Salem M, Bersch D, Abdalla D S. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.  Free Radic Res. 2003;  37 529-536
• 27 Paiva H, Laakso J, Lehtimaki T, Isomustajarvi M, Ruokonen I, Laaksonen R. Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors.  J Cardiovasc Pharmacol. 2003;  41 219-222
• 28 Inoguchi T, Li P, Umeda F, Yu H Y, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells.  Diabetes. 2000;  49 1939-1945
• 29 Davda R K, Stepniakowski K T, Lu G, Ullian M E, Goodfriend T L, Egan B M. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism.  Hypertension. 1995;  26 764-770